Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$2.17 - $35.84 $804,202 - $13.3 Million
-370,600 Reduced 61.13%
235,600 $822,000
Q3 2022

Nov 14, 2022

BUY
$18.3 - $37.02 $11.1 Million - $22.4 Million
606,200 New
606,200 $22.4 Million

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.